At 3 monthsd | At 6 monthse | p interactionb | |||||||
---|---|---|---|---|---|---|---|---|---|
Sepsis (n = 282) | No sepsis (n = 606) | Absolute differencea (95% CI) | p value | Sepsis (n = 282) | No sepsis (n = 606) | Absolute differencea (95% CI) | p value | ||
WHODAS score, % | 31.8 ± 23.5 | 24.0 ± 22.0 | MD, 3.00 (− 1.42 to 7.42) | 0.184 | 26.1 ± 22.1 | 21.5 ± 21.1 | MD, − 1.40 (− 6.03 to 3.23) | 0.554 | 0.020 |
Disability—no. (%) | 73/129 (56.6) | 145/348 (41.7) | RD, 5.88 (− 4.11 to 15.90) | 0.248 | 52/118 (44.1) | 126/330 (38.2) | RD, − 2.44 (− 13.08 to 8.20) | 0.653 | 0.111 |
New disabilityc—no. (%) | 50/126 (39.7) | 114/344 (33.1) | RD, 5.29 (− 4.45 to 15.00) | 0.287 | 42/106 (39.6) | 106/300 (35.3) | RD, 0.00 (− 10.29 to 10.40) | 0.995 | 0.272 |
New disability or death—no. (%) | 146/222 (65.8) | 231/461 (50.1) | RD, 5.22 (− 4.52 to 15.00) | 0.293 | 142/206 (68.9) | 228/422 (54.0) | RD, 0.83 (− 9.47 to 11.10) | 0.874 | 0.360 |
EuroQol-visual analogue scale | 61.0 ± 24.3 | 67.4 ± 22.9 | MD, − 3.82 (− 8.44 to 0.80) | 0.105 | 66.1 ± 20.7 | 71.4 ± 20.1 | MD, − 1.72 (− 6.67 to 3.23) | 0.495 | 0.394 |
EQ-5D-5L™ utility | 0.6 ± 0.3 | 0.7 ± 0.3 | MD, − 0.07 (− 0.13 to − 0.01) | 0.013 | 0.7 ± 0.3 | 0.7 ± 0.3 | MD, − 0.04 (− 0.10 to 0.02) | 0.152 | 0.268 |
No problem with anxiety | 63/129 (48.8) | 195/349 (55.9) | RD, − 7.60 (− 17.50 to 2.31) | 0.132 | 71/118 (60.2) | 196/332 (59.0) | RD, 1.85 (− 8.75 to 12.46) | 0.732 | 0.079 |
No problem with mobility | 49/129 (38.0) | 204/349 (58.5) | RD, − 11.87 (− 21.80 to − 1.95) | 0.019 | 63/118 (53.4) | 220/332 (66.3) | RD, − 4.22 (− 14.90 to 6.45) | 0.438 | 0.182 |
No problem with pain | 51/129 (39.5) | 165/349 (47.3) | RD, − 4.61 (− 15.13 to 5.91) | 0.390 | 56/118 (47.5) | 171/332 (51.5) | RD, 3.04 (− 8.23 to 14.32) | 0.596 | 0.195 |
No problem with personal care | 66/129 (51.2) | 217/349 (62.2) | RD, − 3.84 (− 13.60 to 5.95) | 0.442 | 64/118 (54.2) | 230/332 (69.3) | RD, − 6.74 (− 17.20 to 3.75) | 0.208 | 0.591 |
No problem with usual activities | 34/129 (26.4) | 117/349 (33.5) | RD, − 3.26 (− 13.40 to 6.87) | 0.528 | 37/118 (31.4) | 139/332 (41.9) | RD, − 1.73 (− 12.60 to 9.17) | 0.755 | 0.791 |
Unemployed due to health | 64/129 (49.6) | 162/348 (46.6) | RD, 0.33 (− 9.82 to 10.50) | 0.949 | 52/118 (44.1) | 135/334 (40.4) | RD, − 0.17 (− 10.64 to 10.30) | 0.974 | 0.911 |
IES-R | – | – | – | – | 12.3 ± 14.4 | 8.5 ± 12.5 | MD, 2.27 (− 2.09 to 6.63) | 0.326 | – |
Post-traumatic stress disorder | – | – | – | – | 8/62 (12.9) | 9/184 (4.9) | RD, 7.22 (− 1.45 to 15.85) | 0.116 | – |
IADL | – | – | – | – | 6.5 ± 2.1 | 7.1 ± 1.7 | MD, − 0.56 (− 1.00 to − 0.14) | 0.013 | – |
Fully independent | – | – | – | – | 61/117 (52.1) | 214/327 (65.4) | RD, − 10.86 (− 22.67 to 0.38) | 0.071 | – |
MoCA-BLIND | – | – | – | – | 18.6 ± 2.8 | 18.5 ± 3.1 | MD, − 0.14 (− 1.17 to 0.89) | 0.803 | – |
Cognitive dysfunction | – | – | – | – | 18/61 (29.5) | 50/174 (28.7) | RD, − 0.17 (− 15.79 to 15.45) | 0.983 | – |
HADS anxiety | – | – | – | – | 4.7 ± 4.7 | 4.3 ± 4.3 | MD, 0.81 (− 0.53 to 2.15) | 0.250 | – |
Anxiety | – | – | – | – | 19/73 (26.0) | 47/212 (22.2) | RD, 3.12 (− 9.67 to 15.91) | 0.644 | – |
HADS depression | – | – | – | – | 4.1 ± 3.6 | 3.6 ± 3.8 | MD, 0.54 (− 0.61 to 1.71) | 0.378 | – |
Depression | – | – | – | – | 15/73 (20.5) | 36/208 (17.3) | RD, 7.65 (− 4.53 to 19.84) | 0.234 | – |
Financial distress | 2.7 ± 3.4 | 2.4 ± 3.3 | MD, 0.11 (− 0.63 to 0.86) | 0.766 | 2.2 ± 3.3 | 1.8 ± 3.0 | MD, 0.02 (− 0.77 to 0.82) | 0.954 | 0.816 |